This presentation will address the following learning objectives:

• Outline how IBD pharmacists add value via the delivery of safe, effective and quality care to IBD patients
• Explain the inadequacies with the current funding models for IBD and other chronic diseases
• Describe the benefit of values-based models of care for patients with inflammatory bowel disease
• Outline the role that virtual care models can have on patient outcomes, costs of care delivery and development of sustainable care models for IBD and other chronic diseases